or infected with trypanosomes (14) . The T15 idiotype is the major idiotype of BALB/c mouse anti-phosphorylcholine (PC) antibodies (15) . The cross-reactivity of this idiotype with the idiotype of the TEPC-15 myeloma protein facilitates the detection of anti-T15 idiotype auto-antibodies and the preparation of heterologous anti-T15 idiotype antibodies that are used to detect immunoglobulins bearing T15 idiotypic determinants (16) .
In this report, we investigated whether T15 idiotype-anti-T15 idiotype IC could be involved in the glomerular lesions observed in BALB/c mice injected with LPS. The presence in the kidneys of IC reacting with TEPC-15 myeloma protein or with rabbit anti-Tl5 idiotype antibodies was investigated in immunofluorescence studies and in trace-labeling experiments. In addition, kidney-deposited immunoglobulins were eluted, radiolabeled, and analyzed by solid-phase radioimmunoassay for the presence of T 15 idiotype-bearing molecules and of anti-T 15 idiotype antibodies.
Materials and Methods
Mice. 6-to 8-wk-old female BALB/c mice were purchased from IFFA CREDO (Centre de Recherche et d'Elevage des Oncins, St. Germain-sur-l'Arbresle, France).
LPS. LPS W of Salmonella typhimurium (lot 657763) were obtained from Difco Laboratories,
Detroit, MI. LPS preparations were diluted to the concentration of 250/~g/ml and were injected intraperitoneally in a final volume of 0.2 ml.
Monoclonal Antibodies. The TEPC-15, MOPC-167, and MOPC-460 myeloma proteins were purified by affinity chromatography from the ascites fluid of BALB/c mice transplanted with the corresponding plasmocytoma (17) obtained from Dr. M. Potter (National Institute of Health, Bethesda, MD), as previously described (18, 19) . Briefly, the PC-binding IgA (K) TEPC-15 and MOPC-167 were specifically eluted from a Sepharose glyeyltyrosine PC column, and the dinitrophenyl (DNP)-binding IgA (K) MOPC-460 were eluted from a Sepharose E-N-DNP lysine column. T 15 idiotype-positive IgM monoclonal antibody and HPC-16, another monoclonal anti-PC IgM antibody produced by cell hydidization, were a kind gift from Dr. H. Cosenza (Department of Microbiology, University Nationale, Honduras). Mouse IgG myeloma proteins were purchased from Litton Bionetics, Kensington, MD.
Antigens. DNP-and PC-bovine serum albumin (BSA) conjugates were prepared according to the method of Claflin et al. (15) .
Radiolabeling Procedures. TEPC-15 myeloma protein, MOPC-167 myeloma protein, PC-BSA, and DNP-BSA were radiolabeled with [12~I]Na (Radiochemical Centre, Amersham, England) by the chloramine-T method (20) . In all cases, the specific activity was ~ 1 ftC/ftg. For duallabeling experiments, MOPC-167 was labeled with [13aI]Na, specific activity being 0.2 pC/pg.
Staphylococcal protein A (Pharmacia Fine Chemicals, Uppsala, Sweden) was labeled with [12SI]Na, according to Bolton and Hunter (21) .
Fluorescein Isothiocyanate (FITC) Conjugates. FITC-eonjugated rabbit anti-mouse IgG, rabbit anti-mouse IgM, rabbit anti-mouse C3, and goat anti-rabbit IgG antisera were purchased from Nordic Laboratories, Tilburg, the Netherlands. FITC-conjugated goat anti-rabbit IgG antiserum was adsorbed on a Sepharose mouse IgG column before use. TEPC-15 and MOPC-167 myeloma proteins were conjugated with FITC (Baltimore Biological Laboratories, Cockeysville, MD), according to the method of Kawamura (22) . Fluorochrome to protein ratio was between 2 and 3.
Preparation and Purification of the Rabbit Anti-TEPC-15 Myeloma Protein Antibodies. Three rabbits
were immunized with 1 mg of TEPC-15 myeloma protein ~.n complete Freund's adjuvant and 1 mo later with 1 mg of TEPC-15 myeloma protein in incomplete Freund's adjuvant. The rabbits were bled weekly, and the injection and bleeding schedule were repeated 2 mo later. IgG fraction of rabbit anti-TEPC-15 myeloma protein antisera was obtained by precipitation in 50% ammonium sulfate, followed by diethylaminoethyl (DEAE)-cellulose column chromatography (Whatman DE 23, Whatman Reeve Angel, Clifton, N J) in 0.01 M phosphate buffer, pH 8.0. Non-anti-idiotypic IgG antibodies were removed by immunoadsorption on cyanogen bromide-activated Sepharose 4B (Pharmacia Fine Chemicals, Uppsala, Sweden) coupled to normal BALB/c serum proteins according to Cuatrecasas (23) and, in addition, by adsorption on MOPC-460 and MOPC-167-Sepharose immunosorbents.
Idiotypic Specificity of the Purified Anti-TEPC-15 Myeloma Protein Antibodies. The specificity of the adsorbed IgG fraction for the T15 idiotype was assessed in a solid-phase radioimmunoassay. Polystyrene microtiter tubes (Cooke Laboratory Products, Alexandra, VA) were coated with 100/xl of serial dilutions of TEPC-15 myeloma protein or MOPC-167 myeloma protein in carbonate buffer (0.05 M, pH 9.6) for 3 h at 37°C. The tubes were washed three times with borate-buffered saline (BBS)-Tween (Tween 20, 0.025%). To the empty tubes, 100 #1 of the rabbit anti-TEPC-15 myeloma protein IgG fraction (100 #g/ml) was added and allowed to incubate 3 h at room temperature. Each test was performed in duplicate. As control, tubes were incubated with IgG purified from normal rabbit sera. After this incubation, the tubes were washed three times with BBS-Tween, and 100 #1 of [l~5I]protein A (0.5 #g/ml) was added to each tube and left to incubate overnight at 4°C. Finally, the tubes were washed and counted. As shown in Fig. 1 , the rabbit anti-TEPC-15 myeloma protein IgG fraction reacted with the TEPC-15 myeloma protein but not with the MOPC-167 myeloma protein, another anti-PC IgA (K) that does not bear the TEPC-15 idiotype (24) .
The idiotypic specificity of the anti-TEPC-15 myeloma protein antibodies was also tested by an indirect fluorescent antibody technique on plasmacytoma imprints. TEPC-15, MOPC-460, and MOPC-167 plasmacytoma imprints were fixed in acetone, washed in phosphate-buffered saline (PBS), and incubated with the anti-TEPC-15 myeloma protein antibodies for 30 rain. After three washings in PBS, an FITC-conjugated goat anti-rabbit IgG antiserum was applied for 30 min. Finally, the slides were washed and viewed under a Leitz Orthoplan microscope (E. Leitz, Inc., Rockleigh, N J). TEPC-15 plasma cells were strongly stained, whereas no staining was obtained on MOPC-460 nor on MOPC-167 plasma cells (Fig. 2) .
Detection of Circulating IC by an Amplified Conglutinin-binding Test.
IC were detected by the conglutinin-binding test (25) , as modified by Barnet et al. (26) . Briefly, serum samples were incubated in microtiter polystyrene tubes that had been precoated with purified bovine conglutinin (27) , allowing IC that carry C3bi to react with the solid-phase conglutinin. The conglutinin-bound complexes were then incubated with a goat anti-mouse IgM antiserum. Finally, the complexes were quantitated by measuring the binding of added radiolabeled and eluated according to the method of Lambert and Dixon (29) . Briefly, kidneys were minced and washed five times in PBS and then homogeneized in an "omnimixer" for 2 min at medium speed. The suspension was centrifuged at 3,500 g for 15 min and washed three times in PBS at 4°C. The washed sediment was suspended in 0.02 M citrate buffer, pH 3.2, and incubated at 37°C for 90 rain. The suspension was brought back to 4°C and the molarity to 0.15 M NaC1.
After a eentrifugation at 3,500 g for 15 rain, the supernatant was extensively dialyzed against PBS. The globulin fraction was obtained by precipitation in 50% ammonium sulfate. The eluates were studied by double immunodiffusion and immunoelectrophoresis. The amount of IgG and IgM was estimated by radial immunodiffusion in agar using rabbit anti-mouse IgG and rabbit anti-mouse IgM antisera (Nordic Laboratories) (30) . The globulin fraction of the eluates was labeled with [125I]Na by the chloramine-T method, specific activity being 1 #C/pg. 
Detection of T15 Idiotypic Determinants in Glomerular IC after Injection of Bacterial LPS.
Kidneys were first studied by direct immunofluorescence for the presence of immunoglobulins and complement 0, 6, 12, 18, and 28 d after LPS injection. Diffuse and granular deposits of IgG and IgM were found after LPS administration (Fig. 3) in the mesangial areas as well as along the glomerular capillary walls. Similar deposits of C3 were found in all examined mice from day 12 to day 28. Using a specific indirect immunofluorescence technique, we investigated whether rabbit anti-T15 idiotype antibodies could detect free T15 idiotypic sites within the IC deposited in the glomeruli. From day 6 to day 28 after LPS injection, 13 out of 20 mice showed focal and granular deposits of molecules reacting with the rabbit anti-T15-idiotype antibodies (Fig. 3 ) along glomerular capillary walls and in mesangial areas (Fig. 4 a) . When the slides were incubated with normal rabbit IgG instead of the anti-idiotypic antibodies, no glomerular staining was found. The idiotypic specificity of the deposits was further assessed in inhibition experiments, where the slides were incubated with an excess (1 mg/ml) of the TEPC-15 myeloma protein or of the T15 idiotype-positive IgM monoclonal antibody in addition to the anti-TEPC-15 idiotype antibodies. The addition of T 15 idiotype resulted in a marked inhibition of the glomerular binding of the anti-idiotypic antibodies (Fig. 4b) . In contrast, glomerular staining was still observed when MOPC-460 myeloma protein was added to the anti-idiotypic antibodies.
Glomerular Localization of FITC-conjugated TEPC-15 Myeloma Protein after Intravenous Injection.
The presence in the glomerular IC of anti-T15 idiotype antibodies could not be investigated by conventional in vitro immunofluorescence methods because of unavoidable background staining. Therefore, attempts were made to detect these antibodies using an in vivo staining procedure. In these experiments, FITC-conjugated TEPC-15 myeloma protein was injected intravenously in mice that had been injected 18 d earlier with LPS. Examination of kidney sections after injection of the fluorescent TEPC-15 myeloma protein revealed fine, focal, and granular deposits in mesangial areas and along some glomerular capillary walls in five out of seven mice (Fig. 5 a) . No glomerular staining was found in five control mice injected with FITC-conjugated TEPC-15 myeloma protein. To assess the idiotypic specificity of the glomerular binding of the injected TEPC-15 myeloma protein, similar experiments were performed using FITC-conjugated MOPC-167 myeloma protein, another anti-PC IgA (K) that does not bear the TEPC-15 myeloma idiotype. No glomerular staining was detected after intravenous injection of this myeloma protein in five mice previously injected with LPS (Fig. 5 b) .
Radioisotopic Evaluation of the Renal Localization of TEPC-15 Myeloma Protein after Intravenous Injection.
These experiments were performed to obtain a quantitative confirmation of the specific renal localization of TEPC-15 myeloma protein after in 
Idiotypic Analysis of the Immunoglobulins Eluted from Kidneys. The kidney eluates were
shown by double immunodiffusion and by electrophoretic analysis to contain mouse immunoglobulins but no other mouse serum proteins• The amounts of IgG and IgM estimated by radial immunodiffusion were, respectively, 2.3 and 0.6 ~g/g of kidney.
After radiolabeling, the kidney eluates were investigated by solid-phase radioimmunoassay for the presence of immunoglobulins bearing TI5 idiotypic determinants and anti-T15 idiotype antibodies• First, immunoglobulins bearing T15 idiotypic determinants were detected by incubating the [x25I]eluates in tubes coated with rabbit anti-T15 idiotype antibodies. As shown in Fig. 7a , a significant binding was found that was not detected when the [125I]eluates were incubated in tubes coated with control rabbit IgG. Second, the presence of anti-T15 idiotype antibodies was investigated by incubating the eluates in tubes coated with TEPC-15 myeloma protein. As shown in Fig. 7b, the [a25I] eluates reacted with TEPC-15 myeloma protein but not with two other immunoglobulins that do not bear the TEPC-15 idiotype (HPC-16 antibody and MOPC-460 myeloma protein). To ascertain that immunoglobulins were responsible for the reaction of the radiolabeled eluates with TEPC-15 myeloma protein and with rabbit anti-T15 idiotype antibodies, the radioimmunoassays were repeated after adsorption of the [12SI]eluates on Sepharose 4B coupled to anti-mouse immunoglobulin antibodies. 96% of the binding to TEPC-15 myeloma protein and 98% of the binding to anti-T15 idiotype antibodies was eliminated by this procedure. These experiments allowed us to estimate at 4-5% the proportion of immunoglobulins eluted from kidneys bearing T15 idiotypic determinants. The estimated amount of anti-T15 idiotype antibodies was similar. Discussion A single injection of bacterial LPS in mice has been previously shown (10) to induce glomerular lesions associated with other features of systemic lupus erythematosus, such as the production of anti-DNA antibodies and circulating IC. The glomeruli showed only minimum histologic alterations, but electron microscopy demonstrated electron-dense deposits within the glomerular basement membrane, and immunofluorescence studies showed glomerular deposits of immunoglobulins and complement, suggesting the presence of IC. As LPS injection was followed by (a) release of free DNA in the circulation and (b) polyclonal B cell activation with production of anti-DNA antibodies (31), a possible involvement of DNA-anti-DNA has been considered. A model of in situ formation of DNA-anti-DNA IC in the glomeruli was proposed, based on the affinity of free DNA for the glomerular basement membrane (32) . Indeed, anti-DNA antibodies were eluted from kidneys of mice injected with LPS. However, the anti-DNA antibodies represented only a fraction of the immunoglobulins deposited in the kidneys, suggesting that other IC were also involved (10) .
It has been observed that polyclonal B cell activation, experimentally induced by B cell mitogens or naturally occurring in the course of some autoimmune or infectious diseases, is often associated with the production of circulating IC (3, 5, 10, 11) . This led to suggesting that a wide expression of the B cell repertoire, including rheumatoid factor-like antibodies and anti-idiotype autoantibodies, might generate IC formed by immunoglobulin interactions. Recently (14), we were able to demonstrate the production of immunoglobulins bearing a known idiotype (T15 idiotype) of corresponding anti-idiotypic antibodies and of circulating T15 idiotype-anti-T15 idiotype IC in BALB/c mice injected with LPS 2 or infected with trypanosomes. Therefore, we wondered whether such idiotype-anti-idiotype IC could be involved in the glomerular lesions observed in these mice (3, 10) . In this report, evidence is provided that T15 idiotype-anti-T 15 idiotype IC are deposited in the glomeruli of BALB/c mice injected with LPS. Renal deposition of both T 15 idiotype-bearing immunoglobulins and anti-T 15 idiotype autoantibodies was demonstrated by immunofluorescence studies, trace labeling experiments, and analysis of kidney eluates.
In preliminary experiments, we confirmed the occurrence of both circulating and glomerular IC after LPS injection. As previously observed, 2 we found that some circulating IC contained anti-T 15 idiotype antibodies. The presence of T15 idiotype-anti-T15 idiotype IC in the renal glomeruli was first investigated by a specific immunofluorescence method to detect T15 idiotypic sites. Rabbit anti-T15 idiotype antibodies were found to react with molecules deposited in granular fashion in the glomeruli. As normal rabbit IgG did not show any similar reaction, this binding of anti-idiotypic antibodies is consistent with the presence of immunoglobulins bearing T15 idiotypic determinants within the glomerular IC. This is further supported by the inhibition of the glomerular staining observed when kidney sections were incubated with an excess of T 15 idiotype in addition to the rabbit anti-idiotypic antibodies. This inhibition was idiotype-specific because it was observed with TI5 idiotypicpositive IgM monoclonal antibody as well as with the TEPC-15 myeloma protein used to prepare the rabbit anti-idiotypic antibodies, but not with the MOPC-460 myeloma protein, another IgA(K) that does not bear the T15 idiotype. The analysis of kidney eluates confirmed the renal deposition of immunoglobulins bearing T15 idiotypic determinants. Indeed, radiolabeled eluates were found to react with rabbit anti-T15 idiotype antibodies but not with normal rabbit IgG.
Evidence was also obtained that anti-T15 idiotype autoantibodies were deposited in the kidneys of mice injected with LPS. First, radiolabeled kidney eluates were found to react with the TEPC-15 myeloma protein, but not with a different IgA (K) myeloma protein (MOPC-460) nor with a different anti-PC antibody (HPC-16). The reaction of the eluates with the TEPC-15 myeloma protein was due to immunoglobulin molecules because it was eliminated by immunoadsorption on anti-mouse immunoglobulin antibodies. These data strongly suggest that anti-T15 idiotype antibodies were present among the immunoglobulins eluted from the kidneys. Second, FITC-conjugated TEPC-15 myeloma protein was found to localize in the glomeruli after intravenous injection. This in vivo renal binding was shown to be idiotypespecific and could be quantified in a trace-labeling experiment, as compared with that of MOPC-167 myeloma protein, another PC-binding IgA (K). It is possible that the injected TEPC-15 myeloma protein combined in the circulation with antiidiotypic antibodies before renal deposition. However, the levels of circulating anti-T15 idiotype antibodies are quite low 18 d after LPS injection, 2 and it seems more likely that the TEPC-15 myeloma protein reacted with anti-T15 idiotype antibodies already deposited in the glomeruli.
We think that our observations indicate that after LPS injection in BALB/c mice (a) T15 idiotype-anti-T15 idiotype are deposited in the glomeruli, and (b) circulating immunoglobulins bearing T15 idiotypic determinants are then able to localize in the glomeruli by an idiotype-specific mechanism. The persistance in the kidneys of T15 idiotype-bearing immunoglobulins up to 28 d after LPS injection perhaps reflects a progressive accumulation of these molecules on T15 idiotype-anti-T15 idiotype IC already deposited in the glomeruli. Such in situ rearrangement of glomerular IC has been reported in several models, where it was also thought to contribute to the perpetuation of IC in the glomeruli (33) .
The formation of idiotype-anti-idiotype IC after polyelonal B cell activation probably depends on a simultaneous production of idiotypes and corresponding antiidiotypic antibodies. In these experiments, we demonstrated the occurrence of circulating and glomerular T15 idiotype-anti-T15 idiotype IC, whereas anti-MOPC-460 idiotype and anti-MOPC-167 idiotype antibodies were not detected within IC. The analysis of kidney eluates indicates that T 15 idiotype-anti-T 15 idiotype IC represented only a small proportion of the IC deposited in the kidneys, which can be estimated at 4-5%. Other IC could involve autoantigens such as DNA (I0), but one can speculate that many other idiotypes than the T15 idiotype could participate in the formation of idiotype-anti-idiotype IC. Indeed, it is clear that a variety of idiotypic clones are expressed during polyclonal B cell activation, and one can think that a variety of anti-idiotypic clones are expressed as well (13) . It would be logical that major idiotypeanti-idiotype interactions would mostly involve dominant idiotypes of the antibody repertoire. In addition, idiotype-anti-idiotype IC would only occur for those dominant idiotypes for which corresponding anti-idiotypic antibodies are simultaneously triggered. This hypothesis is consistent with the involvement of the T15 idiotype in idiotype-anti-idiotype IC. This idiotype is a major idiotype of BALB/c mice (15) , expressed on 60-70% of the anti-PC antibodies detected after LPS injection, 2 and we have demonstrated a simultaneous triggering of T 15 idiotypic clones and of anti-T t 5 idiotypic clones during polyclonal B cell activation (14) .
Idiotypic interactions could be involved in the immunopathology of some human diseases. Anti-gamma globulin antibodies have been demonstrated in cryoprecipitates and in kidney lesions of some patients with systemic lupus erythematosus (34) . Recent reports have suggested the participation of anti-idiotypic antibodies in mixed cryoglobulins (35) and the possible occurence of antibodies against idiotypic determinants of anti-DNA antibodies in systemic lupus erythematosus (36) . Idiotype-anti-idiotype IC could be generated in such diseases and participate in the development of ICmediated lesions. Idiotypic interactions could also play some role in diseases associated with repeated antigenic stimulations (16) . The data presented in this paper suggest that idiotype-anti-idiotype IC could be involved in the pathogenesis of some glomerular diseases. This would be consistent with the difficulty to identify specific antigens in many glomerulonephritides associated with immunoglobulin deposits (4). One should consider that the largest source of potential antigens and corresponding antibodies probably exists within the B cell repertoire and that the formation of IC might often represent an exacerbation of physiological interactions within an idiotypic network.
Summary
We investigated the possible role of idiotypic interactions in the pathogenesis of the glomerular lesions observed in mice undergoing polyclonal B cell activation. BALB/c mice were studied for the presence of renal deposits of T15 idiotype-anti-T15 idiotype-immune complexes (IC) after injection of bacterial lipopolysaecharides (LPS). The T 15 idiotype is the major idiotype of BALB/c mice anti-phosphorylcholine (PC) antibodies, which are cross-reactive with the idiotype of the TEPC-15 myeloma protein. This model was used because T15 idiotype-anti-T15 idiotype IC have been detected in the circulation of BALB/c mice after polyclonal B cell activation. First, an idiotype-specific immunofluorescence technique allowed us to detect T t5 idiotypebearing immunoglobulins in glomeruli from day 6 to day 28 after LPS injection. Second, fluorescein isothiocyanate-conjugated TEPC-15 myeloma protein was found to localize in the glomeruli after in vivo injection 18 d after LPS administration. This renal localization was shown to be idiotype-specific and could be quantified in a trace-labeling experiment. Third, kidney-deposited immunoglobulins of mice injected with LPS were eluted, radiolabeled, and analyzed by radioimmunoassay. Both T15 idiotype-bearing immunoglobulins and anti-T 15 idiotype antibodies were detected in the eluates, providing further evidence for a renal deposition of T15 idiotype-anti-T15 idiotype IC.
Polyclonal B cell activation is likely to result in a simultaneous triggering of many idiotypic clones and of corresponding anti-idiotypic clones represented in the B cell repertoire. This could lead to the formation of a variety of idiotype-anti-idiotype IC that could participate in the development of glomerular lesions.
